Details:

Alternative Title:
MMWR Morb Mortal Wkly Rep
Personal Author:
Clarke, Kristie E.N. ; Jones, Jefferson M. ; Deng, Yangyang ; Nycz, Elise ; Lee, Adam ; ... More +
Clarke, Kristie E.N. ; Jones, Jefferson M. ; Deng, Yangyang ; Nycz, Elise ; Lee, Adam ; Iachan, Ronaldo ; Gundlapalli, Adi V. ; Hall, Aron J. ; MacNeil, Adam Less -
Description:
In December 2021, the B.1.1.529 (Omicron) Variants of SARS-CoV-2, the Virus that causes COVID-19, became predominant in the United States Subsequently, national COVID-19 case rates peaked at their highest recorded levels.* Traditional Methods of disease Surveillance do not capture all COVID-19 cases because some are asymptomatic, not diagnosed, or not reported; therefore, the proportion of the population with SARS-CoV-2 antibodies (i.e., seroprevalence) can improve understanding of population-level incidence of COVID-19. This report uses data from CDC's national commercial laboratory seroprevalence study and the 2018 American Community Survey to examine U.S. Trends in infection-induced SARS-CoV-2 seroprevalence during September 2021-February 2022, by age group.
Subjects:
[+]
Antibodies, Viral COVID-19 Humans SARS-CoV-2 Seroepidemiologic Studies
Source:
MMWR Morb Mortal Wkly Rep. 71(17):606-608
Pubmed ID:
35482574
Pubmed Central ID:
PMC9098232
Document Type:
Journal Article
Place as Subject:
United States
Collection(s):
Morbidity and Mortality Weekly Report (MMWR)
Main Document Checksum:
[+]
urn:sha256:acb81e1e45878e06b623b07d1847da5031016a0bd936dad6fb5c4a0b95b70e9a
Download URL:
https://stacks.cdc.gov/view/cdc/118002/cdc_118002_DS1.pdf
File Type:

Supporting Files

• 	mm7117e3-F.gif	gif
  	mm7117e3-F.jpg	jpeg
  	mm7117e3.nxml	xml

More +